Genetic Variation in the SLC19A1 gene and Methotrexate Toxicity in Rheumatoid Arthritis Patients

• Chan ES , CronsteinBN. Molecular action of methotrexate in inflammatory diseases. Arthritis Res.4(4) , 266–273 (2002).
   PubMedGoogle Scholar
• Aletaha D , SmolenJS. The rheumatoid arthritis patient in the clinic: comparing more than 1,300 consecutive DMARD courses. Rheumatology (Oxford)41(12) , 1367–1374 (2002).
   PubMed Web of Science ®Google Scholar
• Maetzel A , WongA, StrandV, TugwellP, WellsG, BombardierC. Meta-analysis of treatment termination rates among rheumatoid arthritis patients receiving disease-modifying anti-rheumatic drugs. Rheumatology (Oxford)39(9) , 975–981 (2000).
   PubMed Web of Science ®Google Scholar
• Taniguchi A , UranoW, TanakaE et al. Validation of the associations between single nucleotide polymorphisms or haplotypes and responses to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a proposal for prospective pharmacogenomic study in clinical practice. Pharmacogenet. Genomics 17(6) , 383–390 (2007).
   PubMed Web of Science ®Google Scholar
• Urano W , TaniguchiA, YamanakaH et al. Polymorphisms in the methylenetetrahydrofolate reductase gene were associated with both the efficacy and the toxicity of methotrexate used for the treatment of rheumatoid arthritis, as evidenced by single locus and haplotype analyses. Pharmacogenetics 12(3) , 183–190 (2002).
   PubMedGoogle Scholar
• Van Ede AE , LaanRF, BlomHJ et al. The C677T mutation in the methylenetetrahydrofolate reductase gene: a genetic risk factor for methotrexate-related elevation of liver enzymes in rheumatoid arthritis patients. Arthritis Rheum. 44(11) , 2525–2530 (2001).
   PubMed Web of Science ®Google Scholar
• Weisman MH , FurstDE, ParkGS et al. Risk genotypes in folate-dependent enzymes and their association with methotrexate-related side effects in rheumatoid arthritis. Arthritis Rheum. 54(2) , 607–612 (2006).
   PubMed Web of Science ®Google Scholar
• Wessels JA , De Vries-Bouwstra JK, Heijmans BT et al. Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymes. Arthritis Rheum.54(4) , 1087–1095 (2006).
   PubMedGoogle Scholar
• Dervieux T , GreensteinN, KremerJ. Pharmacogenomic and metabolic biomarkers in the folate pathway and their association with methotrexate effects during dosage escalation in rheumatoid arthritis. Arthritis Rheum.54(10) , 3095–3103 (2006).
   PubMed Web of Science ®Google Scholar
• Berkun Y , Abou Atta I, Rubinow A et al. 2756GG genotype of methionine synthase reductase gene is more prevalent in rheumatoid arthritis patients treated with methotrexate and is associated with methotrexate-induced nodulosis. J. Rheumatol.34(8) , 1664–1669 (2007).
   PubMed Web of Science ®Google Scholar
• Drozdzik M , RudasT, PawlikA, GornikW, KurzawskiM, HerczynskaM. Reduced folate carrier-1 80G>A polymorphism affects methotrexate treatment outcome in rheumatoid arthritis. Pharmacogenomics J.7(6) , 404–407 (2007).
   PubMed Web of Science ®Google Scholar
• Bohanec Grabar P , LogarD, LestanB, DolzanV. Genetic determinants of methotrexate toxicity in rheumatoid arthritis patients: a study of polymorphisms affecting methotrexate transport and folate metabolism. Eur. J. Clin. Pharmacol.64(11) , 1057–1068 (2008).
   PubMed Web of Science ®Google Scholar
• Grabar PB , RojkoS, LogarD, DolzanV. Genetic determinants of methotrexate treatment in rheumatoid arthritis patients: a study of polymorphisms in the adenosine pathway. Ann. Rheum. Dis69(5) , 931–932 (2010).
   PubMed Web of Science ®Google Scholar
• Owen SA , HiderSL, MartinP, BruceIN, BartonA, ThomsonW. Genetic polymorphisms in key methotrexate pathway genes are associated with response to treatment in rheumatoid arthritis patients. Pharmacogenomics J. doi:10.1038/tpj.2012.7 (2012) (Epub ahead of print).
   Google Scholar
• Chatzikyriakidou A , GeorgiouI, VoulgariPV, PapadopoulosCG, TzavarasT, DrososAA. Transcription regulatory polymorphism -43T>C in the 5´-flanking region of SLC19A1 gene could affect rheumatoid arthritis patient response to methotrexate therapy. Rheumatol. Int.27(11) , 1057–1061 (2007).
   PubMed Web of Science ®Google Scholar
• Johnson GC , EspositoL, BarrattBJ et al. Haplotype tagging for the identification of common disease genes. Nat. Genet. 29(2) , 233–237 (2001).
   PubMed Web of Science ®Google Scholar
• Arnett FC , EdworthySM, BlochDA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31(3) , 315–324 (1988).
   PubMed Web of Science ®Google Scholar
• Van Riel PL , Van Gestel AM. Clinical outcome measures in rheumatoid arthritis. Ann. Rheum. Dis59(Suppl. 1) , I28–I31 (2000).
   PubMed Web of Science ®Google Scholar
• Bruce B , FriesJF. The Stanford Health Assessment Questionnaire: dimensions and practical applications. Health Qual. Life Outcomes1(1) , 20 (2003).
   PubMedGoogle Scholar
• Cockcroft DW , GaultMH. Prediction of creatinine clearance from serum creatinine. Nephron16(1) , 31–41 (1976).
   PubMed Web of Science ®Google Scholar
• Chango A , Emery-FillonN, De Courcy GP et al. A polymorphism (80G->A) in the reduced folate carrier gene and its associations with folate status and homocysteinemia. Mol. Genet. Metab.70(4) , 310–315 (2000).
   PubMed Web of Science ®Google Scholar
• Barrett JC , FryB, MallerJ, DalyMJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics21(2) , 263–265 (2005).
   PubMed Web of Science ®Google Scholar
• Miller SA , DykesDD, PoleskyHF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res.16(3) , 1215 (1988).
   PubMed Web of Science ®Google Scholar
• Livak KJ , SchmittgenTD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-δδC(T)) method. Methods25(4) , 402–408 (2001).
   PubMed Web of Science ®Google Scholar
• Carter KW , MccaskiePA, PalmerLJ. SimHap GUI: an intuitive graphical user interface for genetic association analysis. BMC Bioinformatics9 , 557 (2008).
   PubMedGoogle Scholar
• Dervieux T , FurstD, LeinDO et al. Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis. Arthritis Rheum. 50(9) , 2766–2774 (2004).
   PubMed Web of Science ®Google Scholar
• James HM , GillisD, HissariaP et al. Common polymorphisms in the folate pathway predict efficacy of combination regimens containing methotrexate and sulfasalazine in early rheumatoid arthritis. J. Rheumatol. 35(4) , 562–571 (2008).
   PubMed Web of Science ®Google Scholar
• Takatori R , TakahashiKA, TokunagaD et al. ABCB1 C3435T polymorphism influences methotrexate sensitivity in rheumatoid arthritis patients. Clin. Exp. Rheumatol.24(5) , 546–554 (2006).
   PubMed Web of Science ®Google Scholar
• Dervieux T , WesselsJA, Van Der Straaten T et al. Gene–gene interactions in folate and adenosine biosynthesis pathways affect methotrexate efficacy and tolerability in rheumatoid arthritis. Pharmacogenet. Genomics19(12) , 935–944 (2009).
   PubMed Web of Science ®Google Scholar
• Williams FM , FlintoffWF. Structural organization of the human reduced folate carrier gene: evidence for 5´ heterogeneity in lymphoblast mRNA. Somat. Cell Mol. Genet.24(3) , 143–156 (1998).
   PubMedGoogle Scholar
• Whetstine JR , FlatleyRM, MatherlyLH. The human reduced folate carrier gene is ubiquitously and differentially expressed in normal human tissues: identification of seven non-coding exons and characterization of a novel promoter. Biochem. J.367(Pt 3) , 629–640 (2002).
   PubMed Web of Science ®Google Scholar
• Trevino LR , ShimasakiN, YangW et al. Germline genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effects. J. Clin. Oncol. 27(35) , 5972–5978 (2009).
   PubMed Web of Science ®Google Scholar
• Tiilikainen A , FischerG, GrubicZ et al. Anthropological features of the east European region. In: HLA: Genetic Diversity of HLA Functional and Medical Implication. Proceedings of the 12th International Histocompatibility Workshop and Conference. Charron D (Ed.). EDK: Medical and Scientific International Publisher, Paris, France, 307–313 (1997).
   Google Scholar
• Vidan-Jeras B , JurcaB, DolzanV, JerasM, BreskvarK, BohinjecM. Caucasian Slovenian normal. In: HLA. Gjertson D, Terasaki P (Eds). American Society for Histocompatibility and Immunogenetics, KA, USA, 180–181 (1998).
   Google Scholar

Websites

• Index of /downloads/genotypes/2008-10_phaseII. http://hapmap.ncbi.nlm.nih.gov/downloads/genotypes/2008-10_phaseII/
   Google Scholar
• Kbioscience. www.kbioscience.co.uk
   Google Scholar